Ryman Healthcare’s shares have risen by as much as 7% as investors appear to be buoyed by signs the company’s reset strategy is going to plan, following the release of its 2023 financial results.
The company unveiled a new approach to its business alongside its $902m capital raise earlier this
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
